Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 14(1): 13050, 2024 06 06.
Article in English | MEDLINE | ID: mdl-38844812

ABSTRACT

This study introduces a novel approach for synthesizing a Cu(II)-based coordination polymer (CP), {[Cu(L)(4,4´-OBA)]·H2O}n (1), using a mixed ligand method. The CP was successfully prepared by reacting Cu(NO3)2·3H2O with the ligand 3,6-bis(benzimidazol-1-yl)pyridazine in the presence of 4,4´-H2OBA, demonstrating an innovative synthesis strategy. Furthermore, a novel hydrogel composed of hyaluronic acid (HA) and carboxymethyl chitosan (CMCS) with a porous structure was developed for drug delivery purposes. This hydrogel facilitates the encapsulation of CP1, and enables the loading of paclitaxel onto the composite to form HA/CMCS-CP1@paclitaxel. In vitro cell experiments demonstrated the promising modulation of thyroid cancer biomarker genes S100A6 and ARID1A by HA/CMCS-CP1@paclitaxel. Finally, reinforcement learning simulations were employed to optimize novel metal-organic frameworks, underscoring the innovative contributions of this study.


Subject(s)
Copper , Hydrogels , Paclitaxel , Thyroid Neoplasms , Paclitaxel/chemistry , Paclitaxel/pharmacology , Copper/chemistry , Hydrogels/chemistry , Humans , Thyroid Neoplasms/drug therapy , Thyroid Neoplasms/pathology , Chitosan/chemistry , Chitosan/analogs & derivatives , Cell Line, Tumor , Hyaluronic Acid/chemistry , Coordination Complexes/chemistry , Coordination Complexes/pharmacology , Drug Carriers/chemistry , Metal-Organic Frameworks/chemistry , Metal-Organic Frameworks/pharmacology
2.
World J Clin Cases ; 8(13): 2749-2757, 2020 Jul 06.
Article in English | MEDLINE | ID: mdl-32742985

ABSTRACT

BACKGROUND: Osteonecrosis of the femoral head (ONFH) is a destructive condition most commonly affecting young and middle-aged patients. The leading consequence of ONFH is often a significant articular disability. Effective joint-preserving surgical treatments are urgently needed for patients with early stage ONFH when outcomes of treatment are in general better than the advanced stage disease. AIM: To introduce a new surgery procedure called percutaneous expanded core decompression and mixed bone graft technique, which is a new way of joint-preserving surgical treatments. METHODS: The clinical data of 6 patients with ONFH diagnosed and treated with the procedure called percutaneous expanded core decompression and mixed bone graft technique at The First Hospital of Qiqihar from March 2013 to August 2019 were retrospectively analyzed; the follow-up ended in December 2019. RESULTS: There were 6 male patients with an average age of 43 years in our study. Gratifying results have been obtained from the comparison of Harris hip score, visual analogue scale, and imaging examination before and after operation. CONCLUSION: This new modified technique is simple, safe, and reliable. No serious perioperative complications were observed in our cases. Advantages of the single blade expandable reamer are obvious. The adjuvant substance is inexpensive and easy to obtain. Thus, this technique is an effective joint-preserving surgical treatment for patients with early stage of ONFH.

3.
Cell Death Dis ; 11(2): 88, 2020 02 03.
Article in English | MEDLINE | ID: mdl-32015325

ABSTRACT

Ferroptosis is a new type of cell death that was discovered in recent years and is usually accompanied by a large amount of iron accumulation and lipid peroxidation during the cell death process; the occurrence of ferroptosis is iron-dependent. Ferroptosis-inducing factors can directly or indirectly affect glutathione peroxidase through different pathways, resulting in a decrease in antioxidant capacity and accumulation of lipid reactive oxygen species (ROS) in cells, ultimately leading to oxidative cell death. Recent studies have shown that ferroptosis is closely related to the pathophysiological processes of many diseases, such as tumors, nervous system diseases, ischemia-reperfusion injury, kidney injury, and blood diseases. How to intervene in the occurrence and development of related diseases by regulating cell ferroptosis has become a hotspot and focus of etiological research and treatment, but the functional changes and specific molecular mechanisms of ferroptosis still need to be further explored. This paper systematically summarizes the latest progress in ferroptosis research, with a focus on providing references for further understanding of its pathogenesis and for proposing new targets for the treatment of related diseases.


Subject(s)
Ferroptosis/physiology , Acute Kidney Injury/drug therapy , Acute Kidney Injury/pathology , Antioxidants/metabolism , Cell Death/drug effects , Cell Death/physiology , Ferroptosis/drug effects , Iron/metabolism , Lipid Metabolism , Lipid Peroxidation , Neoplasms/drug therapy , Neoplasms/pathology , Nervous System Diseases/drug therapy , Nervous System Diseases/pathology , Reperfusion Injury/drug therapy , Reperfusion Injury/pathology
SELECTION OF CITATIONS
SEARCH DETAIL